Drug developer Immuron’s Travelan anti-diarrhoea oral antibody product set the company share price alight this morning following positive news from clinical trials in the United States. Travelan, which is made in Melbourne and on sale through Chemist Warehouse, is a non-absorbable, safe product which is composed of anti-bacterial antibodies that boost the gut immune system.…
Pharmaceutical company Immuron Inc has announced strong sales growth of its Travelan product for the prevention of travellers’ diarrhoea. The company reported Travelan sales were up in all markets with sales in the first half of the year rising 55 per cent to $1.7 million. Sales growth in Australia where the product is being advertised…
Rio Tinto spends up big with local suppliers Rio Tinto increased its spend with suppliers and local businesses in Australia to more than $16.1 billion in 2023, as part of the company’s commitment to support communities where it operates. This was an increase of five per cent on the previous year and was spent with…
WA offers new Defence Ready Initiative grants The Western Australian government has opened applications for the latest round of Defence Ready Initiative grants to support local businesses in the defence sector. The purpose of the $200,000 investment is to assist small and medium enterprises enhance their capability, capacity and competitiveness to enter or expand their…
Hanwha tests Huntsman using ADF ammunition Hanwha Defense Australia (HDA) has completed the first stage of LAND 8116 Protected Mobile Fires (PMF) Ordnance Integration Testing utilising Australian Defence Force ammunition (pictured). Using a K9A1 Test Platform and 155mm rounds from two different families of munitions, the testing activity wrapped up in mid-June at the Anheung…
Australia-United Kingdom Free Trade Agreement takes effect The Australia-United Kingdom Free Trade Agreement (A-UKFTA) came into effect this week, eliminating export costs for some manufacturers sending goods to the United Kingdom. The A-UKFTA eliminates tariffs on over 99 per cent of Australian goods exports to the UK, including exports of wine, honey, nuts, and manufactured…
A second new drug from biotechnology company Immuron is to undergo human trials in the United States following a decision by the Food and Drug Administration that allows trials to proceed. The Melbourne company told investors the US Naval Medical Research Centre (NMRC) had received approval to trial the drug targeting Campylobacter and Enterotoxigenic Escherichia…
ASX and NASDAQ-listed biotechnology company Immuron has deprioritised its SARS-Cov-2 R&D to focus on clinical development of more advanced-stage therapeutic drug candidates, it announced on Friday.
Third NASA rocket launches from Arnhem Land Equatorial Launch Australia (ELA), operator of the Arnhem Space Centre (ASC) in the Northern Territory has completed its third and final rocket launch with NASA. The NASA DEUCE mission will help astronomers measure an unstudied part of Centauri A and B’s ultraviolet light spectrum, helping them model stars…
Immuron’s Travelan anti-diarrhoea product has moved to the human clinical trial phase in a program led by the Uniformed Services University in the United States. Travelan, which is made in Melbourne and on sale through Chemist Warehouse, is a non-absorbable, safe product which is composed of anti-bacterial antibodies that work on the gut immune system.…
